ClinicalBiostats

09 · Therapeutic Area

Hematology Clinical Trials

Trials in anemia, hemophilia, sickle cell disease and blood cancers, spanning response rates, bleeding rates and survival endpoints.

378 trials in this area

Statistical methods in hematology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

Hazard ratio Used in 21% of hematology trials · Hazard Ratio Interpretation for Clinicians → Log-rank test Used in 16% of hematology trials · Log-Rank Test for Comparing Survival Curves → Cochran-Mantel-Haenszel test Used in 14% of hematology trials · SAS PROC FREQ for Categorical Data Analysis → Odds ratio Used in 8% of hematology trials · Effect Size Measures in Clinical Research → Cox proportional-hazards model Used in 6% of hematology trials · Cox Proportional Hazards: Model Diagnostics → Non-inferiority trial design Used in 6% of hematology trials · Non-Inferiority Trial Design Principles → ANCOVA Used in 6% of hematology trials · Analyzing Change from Baseline in Clinical Trials → Risk difference Used in 6% of hematology trials · Effect Size Measures in Clinical Research →

All hematology trials

378 results

← All therapeutic areas